Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/15/26 16:38 | 7/13/26 | BLLN | Health | Health | Medical Laboratories | Ten Bosch John Roderick | CA | O | SVP of L | 3 | S | -991 | 116.56 | 0 | -8 | 35 | D | |||||||||||||||
7/15/26 16:38 | 7/13/26 | BLLN | Health | Health | Medical Laboratories | Tsao David | CA | DO | CTO | 4 | M.d | 4,655 | 58.19 | 0 | 80 | 1 | D | |||||||||||||||
7/15/26 16:38 | 7/13/26 | BLLN | Health | Health | Medical Laboratories | Tsao David | CA | DO | CTO | 4 | S.d | -4,655 | 58.19 | 0 | -80 | 1 | D | |||||||||||||||
7/13/26 16:39 | 7/9/26 | BLLN | Health | Health | Medical Laboratories | Atay Oguzhan | CA | DO | CB,CEO | 6 | M.d | 10,279 | 66.32 | 0 | 155 | 477 | 188 | D | ||||||||||||||
7/13/26 16:39 | 7/9/26 | BLLN | Health | Health | Medical Laboratories | Atay Oguzhan | CA | DO | CB,CEO | 6 | S.d | -10,279 | 66.32 | 0 | -155 | 188 | D | |||||||||||||||
7/13/26 16:39 | 7/9/26 | BLLN | Health | Health | Medical Laboratories | Sakakibara Shan Riku | CA | O | Chief Pr | 5 | M.d | 2,820 | 88.11 | 0 | 32 | 18 | 212 | D | ||||||||||||||
7/13/26 16:39 | 7/9/26 | BLLN | Health | Health | Medical Laboratories | Sakakibara Shan Riku | CA | O | Chief Pr | 5 | S.d | -2,820 | 88.11 | 0 | -32 | 212 | D | |||||||||||||||
7/6/26 20:38 | 7/1/26 | BLLN | Health | Health | Medical Laboratories | Johnson Nancy Joann | CA | O | See Rema | 2 | S.m | -1,503 | 101.52 | 0 | -15 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |